Bavarian Nordic monkeypox vaccine Jynneos more effective with two doses

• Jynneos, a vaccine from Bavarian Nordic (OTCPK:BVNKF)(OTCPK:BVNRY) for monkeypox and smallpox, has better efficacy for monkeypox if given as two shots instead of one.
• Just over 900 participants were included in a case-control study analysis. Data published in the MMWR found that those who received one Jynneos jab had adjusted vaccine effectiveness of 75% compared to 86% for two shots.
• As of March 31, 2023, the CDC said that more than 30K monkeypox cases have been reported in the US.
• The researchers noted that more research is needed to determine the duration of protection from the vaccine, adding that monkeypox vaccination among those most at risk remains low.
• A CDC alert sent to doctors on Monday warned there could be a resurgence of monkeypox over the spring and summer due to gatherings.

More on Jynneos

• US doses of Bavarian Nordic's monkeypox vaccine Jynneos administered surpass 540K

• Moderna 2.0: 3 Stocks To Play The Potential Monkeypox Pandemic